| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 9862 | DOTA-RGDfK dimer acetate |
9862.0001: 1 mg per vial 9862.0010: 10 mg per vial Please inquire for customized filling and bulk quantities.
|
|
Precursor for radiometal-labelled RGD-peptide.
|
||
| Molar Mass: 1704.84 | ||
| C75H113N23O23 | ||
| [250612-06-7] (net peptide) | ||
| Colourless freeze-dried solid packaged in dark glass screw cap vials. | ||
| Purity: ≥ 95 % | ||
|
Certificates:
CoA; MS (identity) and HPLC (purity) |
||
|
Chemical Name: CA index name: Cyclo(L-arginylglycyl-L-α-aspartyl-D-phenylalanyl-L-lysyl), 5,5′-[N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-L-glutamoyl]bis- |
||
|
Synonymes: DOTA-cyclo(-Arg-Gly-Asp-D-Phe-Lys-) dimer |
||
|
Literature: 1. Mousa S.A. αν Integrin Affinity/Specificity and Antiangiogenesis Effect of a Novel Tetraaza Cyclic Peptide Derivative, SU015, in Various Species. J. Cardiovasc. Pharmacol. 2005, 45, 462-467. |
||
| 2. Janssen M.L. et al. Tumor Targeting with Radiolabeled ανβ3 Integrin Binding Peptides in a Nude Mouse Model. Cancer Res. 2002, 62, 6146-6151. | ||
| date of product catalogue issue: 05 April 2012 | ||
PDF file product list home page search email legal notice
ICP License: 沪ICP备05000469号-1